No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Jianmin Pharmaceutical Group Co.,Ltd. operates within China, focusing on the production and distribution of traditional Chinese medicines. The company's product line features pediatric pharmaceuticals, prominently sold under its Jianmin and Longmu brand names. In addition to these offerings, Jianmin provides a range of over-the-counter (OTC) drugs, various medical and health products, and consultation services. The firm's main corporate offices are located in Wuhan, China.
www.whjm.comNo one on the platform currently holds 600976.SS.
No tracked institution reports a position in 600976.SS as of their last filing.
No one on the platform has traded 600976.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 7.6% | 19.2% | — | — | — | |
| Rev. Growth % | -4.4% | 6.4% | ||||
| Profit Margin % | 10.7% | 10.8% | 7.4% | |||
| Free Cash Flow Margin % | 5.2% | 4.7% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $4.2B | +9.4% | $3.94 | $3.94–$3.94 | — | 1 |
| 2027 | $4.6B | +8.8% | $4.72 | $4.72–$4.72 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 600976.SSJianmin Pharmaceutical Group Co.,Ltd. | $26.42 | -0.34% | $4.1B | — |
| 002349.SZJinghua Pharmaceutical Group Co., Ltd. | $8.02 | -2.08% | $6.7B | — |
| 002393.SZTianjin Lisheng Pharmaceutical Co.,Ltd. | $13.41 | -0.30% | $4.1B | — |
| 002728.SZTeyi Pharmaceutical Group Co.,Ltd | $9.11 | -0.00% | $4.7B | — |
| 002793.SZLuoxin Pharmaceuticals Group Stock Co., Ltd. | $4.47 | +0.22% | $4.9B | — |
| 002880.SZShenzhen Weiguang Biological Products Co., Ltd. |
Source: Financial Modeling Prep · peers by sector/industry
| $20.26 |
| +0.30% |
| $4.6B |
| — |
| 300039.SZShanghai Kaibao Pharmaceutical CO.,Ltd | $5.02 | -0.00% | $5.3B | — |